CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Evofem Biosciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Evofem Biosciences Inc
12400 High Bluff Drive, Suite 600
Phone: (858) 550-1900p:858 550-1900 SAN DIEGO, CA  92130  United States Ticker: EVFMEVFM

Business Summary
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health. Its commercial product, Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel (Phexxi), is a hormone-free and woman-controlled prescription contraceptive drug product available in the United States. Its lead clinical program is evaluating EVO100 for the prevention of urogenital chlamydia and gonorrhea in women. Its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), EVO200 vaginal gel, uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer Saundra L.Pelletier 53 4/13/2023 1/17/2018
Chief Financial Officer, Company Secretary IvyZhang 45 4/13/2023 4/13/2023
Independent Director KimKamdar 55 1/1/2018 4/1/2011
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Evofem Biosciences Operations Inc 12400 High Bluff Dr Ste 600 SAN DIEGO CA United States
Evofem Inc 12636 High Bluff Drive, Suite 400 SAN DIEGO CA United States

Business Names
Business Name
EVFM
EVFMD
Evofem Biosciences Operations Inc.
6 additional Business Names available in full report.

General Information
Number of Employees: 35 (As of 4/7/2023)
Outstanding Shares: 10,730,210 (As of 11/9/2023)
Shareholders: 61
Stock Exchange: OTC
Federal Tax Id: 208527075
Fax Number: (302) 636-5454
Email Address: info@neothetics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024